Two‑stage diphenhydramine improves early recovery in women after video‑assisted thoracoscopic surgery: a randomized controlled trial
Authors:
- 3 May 2026
- journal article
- research article
- Published by Springer Nature in Journal of Anesthesia
- p. 1-9
Abstract
Purpose Thoracic paravertebral block (TPVB) provides effective analgesia for video-assisted thoracoscopic surgery (VATS). However, even when pain is well-controlled by TPVB, female patients remain at high risk for postoperative nausea and vomiting (PONV) and sleep disturbances because of non-analgesic factors, such as hormonal and central emetic pathways. We investigated whether adding a two-stage diphenhydramine regimen to TPVB-based multimodal analgesia improves early recovery quality. Methods In this prospective, randomized, double-blind, placebo-controlled trial, 80 women (ASA I–III) scheduled for elective VATS pulmonary resection were randomized to receive a two-stage diphenhydramine regimen (0.2 mg/kg bolus at chest closure followed by 0.5 mg/kg via postoperative patient-controlled intravenous analgesia [PCIA]) or placebo (normal saline). All patients received standardized TPVB with 20 mL 0.4% ropivacaine, PCIA with sufentanil/ondansetron, and intravenous dexamethasone 10 mg. The primary outcome was the 24-h Quality of Recovery-15 (QoR-15) score. Secondary outcomes included sleep quality, PONV incidence, pain scores, rescue medication requirements, and adverse events. Results The diphenhydramine group exhibited a significantly higher median 24 h QoR-15 score (127 [IQR 121–134.75] vs. placebo 119.5 [IQR 108.25–130.75], P = 0.033). This group also demonstrated markedly better sleep quality (lower Athens Insomnia Scale scores at 24 and 48 h, P < 0.05) and a significantly reduced incidence of vomiting (10% vs. 40%, P = 0.004). Overall PONV rates and other secondary outcomes were comparable, with no difference in adverse events. Conclusions Adding a two-stage diphenhydramine regimen to TPVB-based multimodal analgesia significantly improves early recovery quality, enhances postoperative sleep, and reduces vomiting in women after VATS, without increasing adverse events. Clinical trial registration Chinese Clinical Trial Registry (ChiCTR2500097837).Keywords
Funding Information
- Kunming Health Science and Technology Talent Program (2024-SW(Reserving)-22)
- Chuncheng Youth Top-notch Talent Support Program (C202014009)
This publication has 25 references indexed in Scilit:
- Fourth Consensus Guidelines for the Management of Postoperative Nausea and VomitingAnesthesia & Analgesia, 2020
- Dose-ranging effect of systemic diphenhydramine on postoperative quality of recovery after ambulatory laparoscopic surgery: a randomized, placebo-controlled, double-blinded, clinical trialJournal of Clinical Anesthesia, 2016
- Minimal Clinically Important Difference for Three Quality of Recovery ScalesAnesthesiology, 2016
- Doxepin and diphenhydramine increased non-rapid eye movement sleep through blockade of histamine H1 receptorsPharmacology Biochemistry and Behavior, 2015
- Development and Psychometric Evaluation of a Postoperative Quality of Recovery ScoreAnesthesiology, 2013
- Comparison and Agreement Between the Richmond Agitation-Sedation Scale and the Riker Sedation-Agitation Scale in Evaluating Patients' Eligibility for Delirium Assessment in the ICUChest, 2012
- Prophylaxis of postoperative nausea and vomiting in elective breast surgeryJournal of Clinical Anesthesia, 2011
- Differential effects of lidocaine and remifentanil on response to the tracheal tube during emergence from general anaesthesiaBritish Journal of Anaesthesia, 2011
- Antiemetic and analgesic-sparing effects of diphenhydramine added to morphine intravenous patient-controlled analgesiaBritish Journal of Anaesthesia, 2005
- Athens Insomnia Scale: validation of an instrument based on ICD-10 criteriaJournal of Psychosomatic Research, 2000